Carl Langren

2016

In 2016, Carl Langren earned a total compensation of $842.8K as Vice President of Finance at NewLink Genetics, a 16% decrease compared to previous year.

Compensation breakdown

Bonus$12,625
Non-Equity Incentive Plan$41,625
Option Awards$346,385
Salary$277,500
Stock Awards$148,089
Other$16,588
Total$842,812

Langren received $346.4K in option awards, accounting for 41% of the total pay in 2016.

Langren also received $12.6K in bonus, $41.6K in non-equity incentive plan, $277.5K in salary, $148.1K in stock awards and $16.6K in other compensation.

Rankings

In 2016, Carl Langren's compensation ranked 9,061st out of 14,075 executives tracked by ExecPay. In other words, Langren earned more than 35.6% of executives.

ClassificationRankingPercentile
All
9,061
out of 14,075
36th
Division
Manufacturing
3,504
out of 5,489
36th
Major group
Chemicals And Allied Products
1,201
out of 1,895
37th
Industry group
Drugs
949
out of 1,538
38th
Industry
Pharmaceutical Preparations
754
out of 1,176
36th
Source: SEC filing on March 31, 2017.

Langren's colleagues

We found five more compensation records of executives who worked with Carl Langren at NewLink Genetics in 2016.

2016

Charles Link

NewLink Genetics

Chief Executive & Scientific Officer

2016

Nicholas Vahanian

NewLink Genetics

Chief Medical Officer

2016

John Henneman

NewLink Genetics

Chief Financial Officer

2016

Brian Wiley

NewLink Genetics

Chief Commercial Officer

2016

Eugene Kennedy

NewLink Genetics

Chief Medical Officer

News

You may also like